Interferon beta-1a as an investigational treatment for CIDP.
about
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathyImmunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathyCytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathyChronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedsideChronic inflammatory demyelinating polyneuropathies: current treatment strategiesChronic inflammatory demyelinating polyneuropathyMultifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variantsEuropean Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the PeAn update on the management of chronic inflammatory demyelinating polyneuropathy.Treatment of dys-immune neuropathies.Treatment of Guillain-Barré syndrome and CIDP.Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Chronic inflammatory demyelinating polyneuropathy: a treatment protocol proposal.Immunotherapy in Peripheral NeuropathiesPredicting treatment response in chronic, acquired demyelinating neuropathies.Matrix metalloproteinases in neuromuscular disease.Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.Current treatments of chronic immune-mediated demyelinating polyneuropathies.Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.Evidence-based treatment of chronic immune-mediated neuropathies.Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.Treatment of refractory chronic inflammatory demyelinating polyneuropathy with interferon beta 1B.
P2860
Q24201954-715157D7-3902-4153-A295-7E48FCD63CF4Q24236599-17130534-2FC5-4D59-9C79-7B8D531FDBBDQ24246094-DCF847C4-8B26-4328-83E8-B118281DA98FQ26823910-0D287D45-9C7F-4753-B449-AC11A9E16902Q28282910-F0BED778-F2E8-4922-BE3D-C2AFA649BD89Q28384089-0020A8F8-3AA7-4DC9-A09F-22EBDBC1A9C4Q28390264-6317C001-B427-4354-91B6-82282604063BQ34619228-AC162966-FB7F-439A-A261-505082C4E4EFQ34645179-1924D35B-3CDC-4DD3-A7D5-9FFC47D53700Q36100132-AD745D68-2E88-4AF9-B1DA-8F7250EF1FDCQ36164126-DA28FD0E-8517-4A80-986D-9EE255C6D1C4Q36365583-F2E63BA3-9C21-49F3-845B-AD107CBDA33CQ36419576-2DCCE07A-6D0F-4989-A4E9-93823743FFB4Q36484418-C9D64E46-472F-4B15-AABD-31AB9B001C11Q36641529-E2C13A55-9C55-44AB-8E79-5EDE91732E22Q36780896-235B5FA0-00CC-4208-BDB7-4A3C8DB0D157Q37350365-EFE81738-51AD-4B6B-B488-FCA2765394F9Q37419250-3AAEF857-4ACA-4702-B7D1-B832D4AA039FQ37507924-CC5E4644-F9F9-4761-9EF7-ADF0B4BC0DA8Q37550515-B1D4CB0B-D177-48C7-902F-8899EFD68FE0Q38711142-76B45AE9-7B57-4052-9776-CCF4108EE7BFQ46932531-6789206F-6B66-4B16-A13E-7130A3926417Q53855159-E281B7E8-353A-429F-A20E-743C89948F5C
P2860
Interferon beta-1a as an investigational treatment for CIDP.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Interferon beta-1a as an investigational treatment for CIDP.
@en
Interferon beta-1a as an investigational treatment for CIDP.
@nl
type
label
Interferon beta-1a as an investigational treatment for CIDP.
@en
Interferon beta-1a as an investigational treatment for CIDP.
@nl
prefLabel
Interferon beta-1a as an investigational treatment for CIDP.
@en
Interferon beta-1a as an investigational treatment for CIDP.
@nl
P2093
P1433
P1476
Interferon beta-1a as an investigational treatment for CIDP.
@en
P2093
Tabaraud F
P356
10.1212/WNL.60.8_SUPPL_3.S23
P407
P433
P50
P577
2003-04-01T00:00:00Z